Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 66.96
-1.35 (-1.98%)
Oct 28, 2026, 10:45 AM CST
SHA:603087 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,183 | 1,144 | 614.66 | 340.07 | -439.52 | 1,453 |
Depreciation & Amortization | 296.09 | 298.41 | 257.45 | 225.26 | 200.34 | 184.88 |
Other Amortization | 9.09 | 6.77 | 1.77 | 1.77 | 1.77 | 1.74 |
Loss (Gain) From Sale of Assets | -3.71 | -3.71 | -1.87 | 17.58 | 80.17 | 0 |
Asset Writedown & Restructuring Costs | -43.15 | -43.15 | -150.88 | 13.38 | 46.58 | 1.69 |
Loss (Gain) From Sale of Investments | -290.78 | -290.78 | -61.25 | -63.33 | -87.57 | -85.63 |
Provision & Write-off of Bad Debts | 2.14 | 2.14 | -20.15 | 15.96 | 27.25 | 19.39 |
Other Operating Activities | 79.61 | -62.15 | -78.34 | -43.57 | -50.7 | -141.11 |
Change in Accounts Receivable | -364.48 | -364.48 | 132.15 | 480.76 | 2,224 | -155.18 |
Change in Inventory | -28.87 | -28.87 | -203.04 | -239.14 | -35.44 | -158.47 |
Change in Accounts Payable | 106.22 | 106.22 | -37.49 | -665.1 | -1,546 | -30.39 |
Change in Other Net Operating Assets | 73.59 | 73.59 | 112.85 | 50.11 | 19.59 | - |
Operating Cash Flow | 965.78 | 784.28 | 537.31 | 109.45 | 296.68 | 1,078 |
Operating Cash Flow Growth | 74.35% | 45.96% | 390.91% | -63.11% | -72.48% | -13.14% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1,331 | -926.09 | -440.8 | -553.06 | -983.44 | -692.08 |
Sale of Property, Plant & Equipment | 0.74 | 0.75 | - | 0.36 | 0.06 | 1.02 |
Divestitures | 309.62 | 309.62 | - | - | - | - |
Investment in Securities | -385.25 | 559.09 | 87.94 | -744.48 | 328.42 | 56.66 |
Other Investing Activities | 206.23 | 92.61 | 90.83 | 319.78 | 212.52 | 136.27 |
Investing Cash Flow | -1,199 | 35.98 | -262.03 | -977.4 | -442.45 | -498.13 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -1.72 | -1.99 | -5.03 | - | - |
Lease Payments | -1.72 | -1.72 | -1.99 | -5.03 | - | - |
Net Debt Issued (Repaid) | 226.36 | -1.72 | -1.99 | -5.03 | - | - |
Issuance of Common Stock | - | - | 139.32 | 759.73 | 71.36 | - |
Repurchase of Common Stock | -116.29 | -138.53 | -17.49 | - | - | - |
Common Dividends Paid | -597.59 | -597.53 | -420.55 | - | -168.46 | -224.62 |
Other Financing Activities | 517.13 | - | - | - | -3.77 | -4.32 |
Financing Cash Flow | 29.61 | -737.77 | -300.71 | 754.7 | -100.87 | -228.93 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -4.96 | 1.17 | -0.95 | 2.36 | 4.19 | -2.68 |
Net Cash Flow | -208.76 | 83.65 | -26.38 | -110.89 | -242.44 | 348.43 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -364.73 | -141.81 | 96.51 | -443.61 | -686.76 | 386.09 |
Free Cash Flow Growth | - | - | - | - | - | -41.43% |
Free Cash Flow Margin | -8.34% | -3.50% | 3.17% | -17.01% | -40.11% | 10.69% |
Free Cash Flow Per Share | -0.62 | -0.24 | 0.16 | -0.78 | -1.22 | 0.69 |
Levered Free Cash Flow | -431.47 | -344.4 | -33.84 | -635.98 | -149.69 | 171.67 |
Unlevered Free Cash Flow | -431.41 | -344.25 | -33.66 | -635.64 | -149.21 | 172.28 |
Free Cash Flow After Leases | -366.45 | -143.53 | 94.51 | -448.64 | -686.76 | 386.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 462.86 | 156.1 | 100.19 | -5 | 116.25 | 323.56 |
Change in Working Capital | -266.84 | -266.84 | -24.09 | -397.66 | 518.36 | -355.55 |